{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T05:05:38Z","timestamp":1789967138445,"version":"4.0.1"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Fluoropyrimidine- and oxaliplatin-based regimens (FOLFOX\/XELOX) are the standard of care for colorectal cancer (CRC) but carry significant cardiovascular toxicity. Malnutrition, present in up to 60% of post-surgical CRC patients, may amplify this toxicity through systemic inflammation and pharmacokinetic alterations; however, this relationship has not been specifically investigated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective cohort study of 320 CRC patients receiving FOLFOX or XELOX at the Shanghai songjiang sijing hospital (January 2020\u2014December 2023). Nutritional status was assessed by the Nutritional Risk Screening 2002 (NRS-2002) and serum albumin. The primary endpoint was chemotherapy-induced cardiovascular toxicity events (CICVT), defined per 2022 ESC Cardio-Oncology Guidelines. Multivariable logistic regression, 1:1 propensity score matching (PSM), and receiver operating characteristic (ROC) analysis were performed. An intestinal fistula subgroup compared outcomes between total parenteral nutrition (TPN) and early enteral nutrition (EEN).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Nutritional risk (NRS-2002 \u2265 3) was identified in 112 patients (35.0%). CICVT occurred in 31.3% of patients at nutritional risk vs. 11.5% of well-nourished patients (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001). After PSM (89 matched pairs), malnutrition remained an independent risk factor (OR 2.93, 95% CI 1.41\u20136.07;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001). Multivariable analysis confirmed NRS-2002 \u2265 3 (adjusted OR 3.18, 95% CI 1.69\u20135.98;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001) and serum albumin &amp;lt; 35\u2005g\/L (adjusted OR 2.43, 95% CI 1.34\u20134.40;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.003) as independent predictors. ROC AUC improved from 0.718 (NRS-2002 alone) to 0.764 when combined with albumin. Among 49 fistula patients, the TPN group had significantly higher CICVT rates than the EEN group (38.7% vs. 16.7%;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.043).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Malnutrition is an independent and modifiable risk factor for chemotherapy-induced cardiovascular toxicity in CRC. Integrating nutritional assessment into pre-chemotherapy cardiovascular risk stratification and prioritizing early enteral nutrition in fistula patients may mitigate cardiovascular morbidity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2026.1936804","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T04:28:23Z","timestamp":1789964903000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Malnutrition as an independent risk factor for fluoropyrimidine- and oxaliplatin-based chemotherapy-induced cardiovascular toxicity in colorectal cancer: a single-center retrospective cohort study"],"prefix":"10.3389","volume":"13","author":[{"given":"Xuyun","family":"Zhou","sequence":"first","affiliation":[{"name":"Department of General Surgery, Shanghai Songjiang Sijing Hospital","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biao","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Ezhou Central Hospital","place":["Ezhou, Hubei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Sheng","sequence":"additional","affiliation":[{"name":"Department of Warehouse, Jinling Hospital, Medical School of Nanjing University","place":["Nanjing, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixia","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Nursing, The Fifth Affiliated Hospital of Xinjiang Medical University","place":["Urumqi, Xinjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.annonc.2022.10.003","article-title":"Metastatic colorectal cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"34","author":"Cervantes","year":"2023","journal-title":"Ann Oncol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1017237","DOI":"10.3389\/fonc.2023.1017237","article-title":"Risk factors for fluoropyrimidine-induced cardiotoxicity in colorectal cancer: a retrospective cohort study and establishment of a prediction nomogram for 5-FU induced cardiotoxicity","volume":"13","author":"Wang","year":"2023","journal-title":"Front Oncol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3892\/or.2022.8468","article-title":"Fluoropyrimidine-induced cardiotoxicity in colorectal cancer patients: a prospective observational trial (CHECKPOINT)","volume":"49","author":"Lombardi","year":"2023","journal-title":"Oncol Rep"},{"key":"B5","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","article-title":"2022 ESC guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society For Therapeutic Radiology And Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)","volume":"43","author":"Lyon","year":"2022","journal-title":"Eur Heart J"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1231401","DOI":"10.3389\/fphar.2023.1231401","article-title":"Oxaliplatin-induced peripheral neurotoxicity in colorectal cancer patients: mechanisms, pharmacokinetics and strategies","volume":"14","author":"Cheng","year":"2023","journal-title":"Front Pharmacol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"21579","DOI":"10.1002\/cam4.6662","article-title":"Risks of hypertension and thromboembolism in patients receiving bevacizumab with chemotherapy for colorectal cancer: a systematic review and meta-analysis","volume":"12","author":"Chitkara","year":"2023","journal-title":"Cancer Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.1016\/j.clnu.2021.02.005","article-title":"ESPEN practical guideline: clinical nutrition in cancer","volume":"40","author":"Muscaritoli","year":"2021","journal-title":"Clin Nutr"},{"key":"B9","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/ncp.11245","article-title":"Use of parenteral nutrition in the management of enterocutaneous fistula","volume":"40","author":"Kumpf","year":"2025","journal-title":"Nutr Clin Pract"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1016\/j.clnu.2023.07.019","article-title":"ESPEN guideline on chronic intestinal failure in adults - update 2023","volume":"42","author":"Pironi","year":"2023","journal-title":"Clin Nutr"},{"key":"B11","doi-asserted-by":"publisher","first-page":"dju124","DOI":"10.1093\/jnci\/dju124","article-title":"Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis","volume":"106","author":"Templeton","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1546465","DOI":"10.3389\/fphar.2025.1546465","article-title":"Effect of hypoalbuminemia on drug pharmacokinetics","volume":"16","author":"Idasiak-Piechocka","year":"2025","journal-title":"Front Pharmacol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e70519","DOI":"10.1002\/cam4.70519","article-title":"Summary of evidence on nutritional management for patients undergoing chemotherapy","volume":"13","author":"Dan","year":"2024","journal-title":"Cancer Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.18632\/oncotarget.28075","article-title":"Pan-drug mechanisms of 5-FU, irinotecan, oxaliplatin, and cisplatin in colorectal cancer cells","volume":"12","author":"Carlsen","year":"2021","journal-title":"Oncotarget"},{"key":"B15","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S0261-5614(02)00214-5","article-title":"Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials","volume":"22","author":"Kondrup","year":"2003","journal-title":"Clin Nutr"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e58514","DOI":"10.7759\/cureus.58514","article-title":"Correlation of the nutritional risk screening 2002 score with post-operative complications in gastrointestinal and hepatopancreatobiliary oncosurgeries","volume":"16","author":"Limbu","year":"2024","journal-title":"Cureus"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e057765","DOI":"10.1136\/bmjopen-2021-057765","article-title":"Applicability of five nutritional screening tools in Chinese patients undergoing colorectal cancer surgery: a cross-sectional study","volume":"12","author":"Xie","year":"2022","journal-title":"BMJ Open"},{"key":"B18","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"key":"B19","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"B20","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/2050-6511-15-47","article-title":"A systematic review of the pathophysiology of 5-fluorouracil-induced cardiotoxicity","volume":"15","author":"Polk","year":"2014","journal-title":"BMC Pharmacol Toxicol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"164","DOI":"10.5847\/wjem.j.1920-8642.2025.024","article-title":"Cardiac complications in acute pancreatitis: an under-diagnosed clinical concern","volume":"16","author":"Pan","year":"2025","journal-title":"World J Emerg Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1631484","DOI":"10.3389\/fnut.2025.1631484","article-title":"Nutritional and inflammatory biomarkers in predicting spontaneous anastomotic leakage closure following enterocutaneous fistula resection","volume":"12","author":"Yu","year":"2025","journal-title":"Front Nutr"},{"key":"B23","doi-asserted-by":"publisher","first-page":"51","DOI":"10.5847\/wjem.j.1920-8642.2025.020","article-title":"ICU-acquired weakness in critically ill patients at risk of malnutrition: risk factors, biomarkers, and early enteral nutrition impact","volume":"16","author":"Zheng","year":"2025","journal-title":"World J Emerg Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40959-024-00294-2","article-title":"Cardiovascular safety of 5-fluorouracil and capecitabine in colorectal cancer patients: real-world evidence","volume":"11","author":"Wong","year":"2025","journal-title":"Cardio-Oncology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1002\/ejhf.1920","article-title":"Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group Of The Heart Failure Association of the European Society of Cardiology in collaboration with the international cardio-oncology society","volume":"22","author":"Lyon","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clnu.2018.08.002","article-title":"GLIM Criteria for the diagnosis of malnutrition: a consensus report from the global clinical nutrition community","volume":"38","author":"Cederholm","year":"2019","journal-title":"Clin Nutr"},{"key":"B27","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1002\/jso.27366","article-title":"Malnutrition defined by GLIM criteria identifies a higher incidence of malnutrition and is associated with pulmonary complications after oesophagogastric cancer surgery","volume":"128","author":"Murnane","year":"2023","journal-title":"J Surg Oncol"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1936804\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T04:28:23Z","timestamp":1789964903000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1936804\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,21]]},"references-count":27,"alternative-id":["10.3389\/fcvm.2026.1936804"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1936804","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,21]]},"article-number":"1936804"}}